25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages

By  

Current Pharmaceutical Design, Vol. 21, Iss. 17, 2015-05 ,pp. : 2243-2249

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments of 2–Substituted Analogs of 1,25(OH)2D3

By  

Current Medicinal Chemistry, Vol. 20, Iss. 16, 2013-05 ,pp. : 2080-2095

Bentham Science Publishers

Access to resources Recommend Favorite

[ 3 H]7-OH-DPAT is capable of labeling dopamine D 2 as well as D 3 receptors

By Gonzalez A.M.   Sibley D.R.  

European Journal of Pharmacology, Vol. 272, Iss. 1, 1995-01 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

The dopamine D 3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for d-amphetamine or cocaine

By Baker L.E.   Svensson K.A.   Garner K.J.   Goodwin A.K.  

European Journal of Pharmacology, Vol. 358, Iss. 2, 1998-10 ,pp. : 101-109

Elsevier

Access to resources Recommend Favorite

3D-QSAR Study of Flavone Derivatives as Inhibitors of HeLa Cervix Adenocarcinoma Cell Lines

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 7, 2015-01 ,pp. : 537-544

Bentham Science Publishers

Access to resources Recommend Favorite